Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia

1. Ramos Elbal, E.
2. Fuster, J.L.
3. Campillo, J.A.
4. Galera, A.M.
5. Cortés, M.B.
6. Llinares, M.E.
7. Jiménez, I.
8. Plaza, M.
9. Banaclocha, H.M.
10. Galián, J.A.
11. Blanquer Blanquer, M.
12. Martínez Sánchez, M.V.
13. Muro, M.
14. Minguela, A.